Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. - Pavord, I; Korn, S; Howarth, P; Bleecker, E; Buhl, R; Keene, O; Ortega, H; Chanez, P (Lancet (London, England), 2012)